This product includes the webinar and SAM credit

---

Speaker: Jonathan Nowak, MD, PhD	Moderator: Jeremy Segal, MD, PhD

 

Description: This webinar will cover the methodology for calculating tumor mutational burden (TMB) and will review technical considerations that can impact TMB calculation. The utility of detecting the underlying mutational processes that determine a tumor's mutational burden will also be discussed. The course will cover an overview of immunotherapy drugs, targets, and tumor types for which TMB has been used as a biomarker.

Duration: 1 hr

Level of Instruction: Basic

Last day to purchase course and claim credit: December 31, 2020

Maximum SAM credit available: 1.0

This webinar is part 2 of a three-part series exploring how measuring tumor mutational burden can improve patient care. If you'd like more information about the series go here.

This program has been supported through an educational grant from Bristol-Myers Squibb.

---

How to claim credit: To earn SAM credit, all learners must watch the webinar, achieve a minimum score of 80% on the online quiz, and complete an online survey. To access the quiz, click "Submit credit" on the course homepage or click on "My Credit" on the menu to the left and then "submit credit" for the appropriate course.

This course is approved by the American Board of Pathology for 1.0 SAM credits.Physicians should only claim credit commensurate with the extent of their participation in the activity. Participants must successfully complete the online modular exams (answering at least 80% of the questions in a topic module correctly).

SAM questions edited by: Alan Brown, MD

---

You may also be interested in:

• More webinars in this series
• AMP Europe 2018: Presentation Recordings: INNOVATION LAB: Tumor Mutational Burden
• AMP Europe 2018: Presentation Recordings: EMERGING KNOWLEDGE: Immunotherapies
• More on AMPED^TM

Note: Members of AMP can access many of the webinars at no cost or a deep discount. Join the AMP Family!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

Describe laboratory and bioinformatic factors that can influence TMB calculation.
Describe the underlying mutational processes that give rise to a tumor's mutational burden

Pre-Test: Tumor Mutational Burden: Best Practices to Address Clinical and Technical Challenges (+SAM)

Tumor Mutational Burden: Best Practices to Address Clinical and Technical Challenges

Post-Test: TMB: Best Practices to Address Clinical and Technical Challenges (+SAM)

QA Session

How to Claim SAM

Individual topic purchase: Selected